Data Analysis Pre-Market: Peregrine Pharmaceuticals, American Airlines, Growlife, and Ariad Pharmaceuticals
January 14 2014 - 7:00AM
InvestorsHub NewsWire
Peregrine Pharmaceuticals, Inc.
(NASDAQ: PPHM) a biopharmaceutical company, engages in the
development of monoclonal antibodies focused on the treatment and
diagnosis of cancer. The company has received FDA Fast Track
designation for one of its products. Get the details at the
following link: http://bit.ly/AnalysisPPHM copy and paste to
browser may be required
American
Airlines Group, Inc. (NASDAQ: AAL) through its subsidiaries,
operates in the airline industry. It operates an average of
approximately 6,700 flights per day to approximately 339
destinations in 54 countries. AAL has reported December results and
discussed consolidating the customer loyalty programs of American
airlines and US Airways. Get the detail here, at the link: http://bit.ly/AnalysisAAL copy and paste to browser
may be required
Growlife, Inc.
(OTCQB: PHOT) is a diversified company operating in the legal
cannabis industry which develops, markets and deploys products and
services addressing the needs of legal cannabis growing and retail
operations, including hydroponic growing equipment and retail
support software. The company has added a new member to its board
of directors. Find out how the new board member may help the growth
process at PHOT at this link: http://bit.ly/AnalysisPHOT copy
and paste to browser may be required
Ariad Pharmaceuticals, Inc.
(NASDAQ: ARIA) is an oncology company, focused on the
discovery, development, and commercialization of medicines for
cancer patients. ARIA has issued updated on the progress of its
products in development. Get a full report at the link: http://bit.ly/AnalysisARIA copy and paste to browser
may be required
Get our stock alerts ahead of
the crowd on your mobile device text keyword “Street” to
25827
EDITOR NOTES:
1. Information in this release is
fact checked and produced on a best efforts basis and reviewed by
Marc Bonacci, Chief Financial Analyst. However, we are only human
and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
2. This information is submitted as a
net-positive to companies mentioned, to increase awareness for
mentioned companies to our subscriber base and the investing
public.
3. If you wish to have your company
covered in more detail by our team, or wish to learn more about our
services, please contact us at editor@smallcapstreet.com.
4. For any urgent concerns or
inquiries, please contact us at compliance@smallcapstreet.com.
5. Are you a public company? Would
you like to see similar coverage on your company? Send us a full
investors' package to research@smallcapstreet.com for
consideration.
COMPLIANCE PROCEDURE
Content is researched, written and
reviewed on a best-effort basis. This document, article or report
is prepared by Small Cap Specialists, LLC and authored by Marc
Bonacci, Chief Financial Analyst. An outsourced research services
provider represented by Marc Bonacci, Chief Financial Analyst, has
only reviewed the information provided by Small Cap Specialists,
LLC in this article or report. Small Cap Specialists, LLC is not
entitled to veto, interfere or alter the articles, documents or
report once reviewed by the outsourced research provider
represented by Marc Bonacci, Chief Financial Analyst.
NOT FINANCIAL ADVICE
Small Cap Specialists, LLC makes no
warranty, expressed or implied, as to the accuracy or completeness
or fitness for a purpose (investment or otherwise), of the
information provided in this document. This information is not to
be construed as personal financial advice. Readers are encouraged
to consult their personal financial advisor before making any
decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Small Cap Specialists, LLC is not
responsible for any error which may be occasioned at the time of
printing of this document or any error, mistake or shortcoming. No
liability is accepted by Small Cap Specialists, LLC whatsoever for
any direct, indirect or consequential loss arising from the use of
this document. Small Cap Street, LLC expressly disclaims any
fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Small Cap Specialists, LLC does not
(1) guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
SOURCE: SmallCapStreet.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Jul 2024 to Aug 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Aug 2023 to Aug 2024